We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » Senesco Opens New Clinical Trial Site at Seattle Cancer Care Alliance
Senesco Opens New Clinical Trial Site at Seattle Cancer Care Alliance
October 28, 2013
Senesco has enrolled its first patients at a new clinical trial site in Seattle. The company is beginning a Phase Ib/IIa trial of its SNS01-T drug for B-cell cancer. Pharmaceutical Business Review
